Tsfg LLC Sells 411 Shares of CVS Health Co. (NYSE:CVS)

Tsfg LLC cut its position in CVS Health Co. (NYSE:CVS) by 2.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,937 shares of the pharmacy operator’s stock after selling 411 shares during the quarter. Tsfg LLC’s holdings in CVS Health were worth $1,128,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. First Community Trust NA boosted its position in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares during the period. Kathleen S. Wright Associates Inc. bought a new position in shares of CVS Health during the third quarter valued at $33,000. Creekmur Asset Management LLC acquired a new position in shares of CVS Health during the fourth quarter worth $34,000. Steph & Co. grew its stake in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the last quarter. Finally, ORG Partners LLC raised its position in CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the topic of a number of analyst reports. Wells Fargo & Company upped their price target on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Barclays upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $63.00 to $82.00 in a report on Thursday, October 10th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 price objective on shares of CVS Health in a research note on Wednesday, September 4th. Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. Finally, Evercore ISI upped their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.26.

CVS Health Stock Performance

NYSE CVS opened at $65.01 on Wednesday. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The company has a fifty day simple moving average of $59.45 and a 200 day simple moving average of $60.70. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a market cap of $81.61 billion, a P/E ratio of 11.43, a PEG ratio of 0.93 and a beta of 0.54.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 EPS. Sell-side analysts predict that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.09%. CVS Health’s payout ratio is 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.